Home
About
Overview
Sharing Data
ORCID
Help
History (64)
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial.
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).
Dictyocaulus
Prospects for vaccination against herpes simplex virus.
Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma.
See All 64 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma.
Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma. J Surg Res. 1988 Jul; 45(1):15-20.
View in:
PubMed
subject areas
Adenocarcinoma
Humans
Neoplasm Staging
Oncogenes
Prognosis
Protein Biosynthesis
Rectal Neoplasms
Retrospective Studies
Time Factors